Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gattacceca, F.
Right arrow Articles by Jaurand, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gattacceca, F.
Right arrow Articles by Jaurand, M.-C.
Clinical Cancer Research Vol. 8, 3298-3304, October 2002
© 2002 American Association for Cancer Research

Experimental Therapeutics, Preclinical Pharmacology

Ad-IFN{gamma} Induces Antiproliferative and Antitumoral Responses in Malignant Mesothelioma1

Florence Gattacceca, Yannick Pilatte, Christian Billard, Isabelle Monnet, Sylviane Moritz2, Jérôme Le Carrou, Marc Eloit and Marie-Claude Jaurand3

Equipe INSERM EMI.99.09 [F. G., Y. P., I. M., S. M., J. L. C., M-C. J.] and Unité INSERM U448 [C. B.], Faculté de Médecine Paris XII, 94010 Creteil Cedex, France; Service de Pneumologie, Centre Hospitalier Intercommunal, 94010 Créteil Cedex, France [I. M.]; and UMR INRA-AFSSA 1161, Ecole Nationale Vétérinaire d’Alfort, 94704 Maisons-Alfort, France [M. E.]

Purpose: The aim of the work was to investigate the effects of adenovirus(Ad)-mediated IFN{gamma} gene transfer on human mesothelioma (HM) cell proliferation in vitro and growth in nude mice.

Experimental Design: We constructed an E1E3-deleted replication-defective recombinant Ad carrying the human IFN{gamma}gene (Ad-IFN{gamma}) and tested its activity in vitro on HM cell lines established in our laboratory and in a nude mice model.

Results: In vitro, infection of HM cells with Ad-IFN{gamma} led to a prolonged production of an active cytokine in the 10 HM cell lines tested and also led to an antiproliferative effect on the HM cells previously demonstrated as responsive to exogenous recombinant human IFN{gamma}. In nude mice, s.c. inoculation of HM cells from one responsive HM cell line previously infected with Ad-IFN{gamma} resulted in a delay in tumor development, and injection of Ad-IFN{gamma} in preestablished tumors restrained tumor development.

Conclusions: These results indicate for the first time that HM cells are efficiently transduced by Ad-IFN{gamma} and produce an active cytokine for several days. IFN{gamma} produced by gene transfer is shown to have both an antiproliferative effect in vitro and an antitumoral effect in vivo in a nude mice model.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. Wu, X. Xiao, P. Zhao, G. Xue, Y. Zhu, X. Zhu, L. Zheng, Y. Zeng, and W. Huang
Minicircle-IFN{gamma} Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal Carcinoma
Clin. Cancer Res., August 1, 2006; 12(15): 4702 - 4713.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.